185 related articles for article (PubMed ID: 15364638)
1. OxyContin abuse and diversion and efforts to address the problem: highlights of a government report.
Government Accounting Office
J Pain Palliat Care Pharmacother; 2004; 18(3):109-13. PubMed ID: 15364638
[TBL] [Abstract][Full Text] [Related]
2. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
Cicero TJ; Inciardi JA; Muñoz A
J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
[TBL] [Abstract][Full Text] [Related]
3. Addressing OxyContin abuse.
FDA Consum; 2001; 35(4):3. PubMed ID: 11692884
[No Abstract] [Full Text] [Related]
4. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
[TBL] [Abstract][Full Text] [Related]
5. A profile of OxyContin addiction.
Hays LR
J Addict Dis; 2004; 23(4):1-9. PubMed ID: 15339710
[TBL] [Abstract][Full Text] [Related]
6. OxyContin abuse and overdose.
Aquina CT; Marques-Baptista A; Bridgeman P; Merlin MA
Postgrad Med; 2009 Mar; 121(2):163-7. PubMed ID: 19332974
[TBL] [Abstract][Full Text] [Related]
7. States respond to growing abuse of painkiller.
Wasserman S
State Legis; 2001; 27(9):33-4. PubMed ID: 11763873
[TBL] [Abstract][Full Text] [Related]
8. Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder.
Cassidy TA; Thorley E; Black RA; DeVeaugh-Geiss A; Butler SF; Coplan P
J Opioid Manag; 2017; 13(6):425-440. PubMed ID: 29308589
[TBL] [Abstract][Full Text] [Related]
9. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain.
Yu SY;
Oncology; 2008; 74 Suppl 1():46-51. PubMed ID: 18758197
[TBL] [Abstract][Full Text] [Related]
10. OxyContin: maintaining availability and efficacy while preventing diversion and abuse.
Regan JJ; Alderson A
Tenn Med; 2003 Feb; 96(2):88-90. PubMed ID: 12645369
[No Abstract] [Full Text] [Related]
11. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe postherpetic neuralgia pain.
Fan BF;
Oncology; 2008; 74 Suppl 1():66-71. PubMed ID: 18758201
[TBL] [Abstract][Full Text] [Related]
12. The effect of FDA approval of a generic competitor to OxyContin (oxycodone HCl controlled-release) tablets on the abuse of oxycodone.
Bailey JE; Barton PL; Lezotte D; Lowenstein SR; Dart RC
Drug Alcohol Depend; 2006 Sep; 84(2):182-7. PubMed ID: 16510252
[TBL] [Abstract][Full Text] [Related]
13. Companies to pay $39.5m in OxyContin and Risperdal cases.
McCarthy M
BMJ; 2015 Dec; 351():h7018. PubMed ID: 26721284
[No Abstract] [Full Text] [Related]
14. Impact of abuse-deterrent OxyContin on prescription opioid utilization.
Hwang CS; Chang HY; Alexander GC
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):197-204. PubMed ID: 25393216
[TBL] [Abstract][Full Text] [Related]
15. What is being done to address the new drug epidemic?
Dekker AH
J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES21-6. PubMed ID: 17908827
[TBL] [Abstract][Full Text] [Related]
16. Monitoring risk: post marketing surveillance and signal detection.
Dart RC
Drug Alcohol Depend; 2009 Dec; 105 Suppl 1():S26-32. PubMed ID: 19748743
[TBL] [Abstract][Full Text] [Related]
17. An exploratory study of OxyContin use among individuals with substance use disorders.
Levy MS
J Psychoactive Drugs; 2007 Sep; 39(3):271-6. PubMed ID: 18159780
[TBL] [Abstract][Full Text] [Related]
18. Non-medical use of OxyContin Tablets in the United States.
Sees KL; Di Marino ME; Ruediger NK; Sweeney CT; Shiffman S
J Pain Palliat Care Pharmacother; 2005; 19(2):13-23. PubMed ID: 16061457
[TBL] [Abstract][Full Text] [Related]
19. Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring Program.
Vosburg SK; Haynes C; Besharat A; Green JL
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1044-1052. PubMed ID: 28653782
[TBL] [Abstract][Full Text] [Related]
20. OxyContin and neonatal abstinence syndrome.
Rao R; Desai NS
J Perinatol; 2002 Jun; 22(4):324-5. PubMed ID: 12032797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
